Vir Biotechnology Inc (VIR)
9.72
-0.21
(-2.11%)
USD |
NASDAQ |
May 17, 16:00
9.72
0.00 (0.00%)
After-Hours: 20:00
Vir Biotechnology Cash and Short Term Investments (Quarterly): 1.150B for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 1.150B |
December 31, 2023 | 1.522B |
September 30, 2023 | 1.697B |
June 30, 2023 | 1.847B |
March 31, 2023 | 2.250B |
December 31, 2022 | 2.402B |
September 30, 2022 | 2.346B |
June 30, 2022 | 2.196B |
March 31, 2022 | 1.260B |
December 31, 2021 | 708.14M |
September 30, 2021 | 939.45M |
Date | Value |
---|---|
June 30, 2021 | 826.06M |
March 31, 2021 | 733.03M |
December 31, 2020 | 736.86M |
September 30, 2020 | 826.60M |
June 30, 2020 | 552.38M |
March 31, 2020 | 355.61M |
December 31, 2019 | 383.44M |
September 30, 2019 | 320.21M |
June 30, 2019 | 356.55M |
December 31, 2018 | 98.44M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
320.21M
Minimum
Sep 2019
2.402B
Maximum
Dec 2022
1.170B
Average
883.02M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
Vertex Pharmaceuticals Inc | 10.17B |
SeaStar Medical Holding Corp | 0.176M |
NovaBay Pharmaceuticals Inc | 1.823M |
Palatin Technologies Inc | 10.01M |
iBio Inc | 2.788M |